Search research articles
Contact Us
Filters
Showing results (251-260 of 587) with videos related to
Page
of 59
Sort By:
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure response
P Riederer, G P Reynolds, K Jellinger, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1978
Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson's disease and in liver cirrhosis
P Riederer, W D Rausch, W Birkmayer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 17, 2002
Involvement of dopamine in the progression of AIDS Dementia Complex
E Koutsilieri, S Sopper, C Scheller, et al.
Life Sciences
|
January 1, 1997
Blood transferrin and ferritin in Alzheimer's disease
P Fischer, M E Götz, W Danielczyk, et al.
Journal of Neurochemistry
|
January 1, 1988
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents
W D Rausch, Y Hirata, T Nagatsu, et al.
Journal of Neurochemistry
|
March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
E Sofic, W Paulus, K Jellinger, et al.
Journal of Neural Transmission
|
January 1, 1978
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration
G P Reynolds, P Riederer, M Sandler, et al.
Journal of Neurochemistry
|
May 29, 1998
In vitro studies of ferritin iron release and neurotoxicity
K L Double, M Maywald, M Schmittel, et al.
Neurochemistry International
|
March 1, 1993
The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approach
M E Götz, A Dirr, A Freyberger, et al.
Functional Neurology
|
October 1, 1988
Secondary (toxic) parkinsonism as model of Parkinson's disease
P Riederer, E Sofic, G Heuschneider, et al.
Page
of 59
Search research articles
Search
Showing results (251-260 of 587) with videos related to
Sort By:
Page
of 59
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure response
P Riederer, G P Reynolds, K Jellinger, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1978
Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson's disease and in liver cirrhosis
P Riederer, W D Rausch, W Birkmayer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 17, 2002
Involvement of dopamine in the progression of AIDS Dementia Complex
E Koutsilieri, S Sopper, C Scheller, et al.
Life Sciences
|
January 1, 1997
Blood transferrin and ferritin in Alzheimer's disease
P Fischer, M E Götz, W Danielczyk, et al.
Journal of Neurochemistry
|
January 1, 1988
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents
W D Rausch, Y Hirata, T Nagatsu, et al.
Journal of Neurochemistry
|
March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
E Sofic, W Paulus, K Jellinger, et al.
Journal of Neural Transmission
|
January 1, 1978
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration
G P Reynolds, P Riederer, M Sandler, et al.
Journal of Neurochemistry
|
May 29, 1998
In vitro studies of ferritin iron release and neurotoxicity
K L Double, M Maywald, M Schmittel, et al.
Neurochemistry International
|
March 1, 1993
The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approach
M E Götz, A Dirr, A Freyberger, et al.
Functional Neurology
|
October 1, 1988
Secondary (toxic) parkinsonism as model of Parkinson's disease
P Riederer, E Sofic, G Heuschneider, et al.
Page
of 59